Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
BrightEdge
AtlantaSeed–Late Stage
2 people
Capricornio Capital
Growth–Late Stage$1M – $10M
Cdh Venture Management Company Limited
Hong KongSeed–Late Stage$7.1M – $300M
Coolidge Corner Investment
SeoulSeed–Late Stage$223K – $11M
CBC Group
SingaporeSeed–Late Stage
2 people
Wellcome Trust
LondonSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
2 people
Hanne Capital
ShanghaiSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
YF Capital
Hong KongSeed–Late Stage
Augere Venture
KrakówSeed–Late Stage
1 person
Healthequity
BarcelonaSeed–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
RecapHealth Ventures
VancouverSeed–Late Stage
1 person
JAIC
Palo AltoSeed–Late Stage
PTV Healthcare Capital
SingaporeSeries B–Late Stage
Roadmap Capital Inc.
TorontoSeed–Late Stage
SDIC Venture Capital
BeijingSeed–Late Stage
3H Health Investment
ShanghaiSeries A–Late Stage
Onex Corporation
TorontoGrowth–Late Stage
Imperial Capital Group Ltd
TorontoGrowth–Late Stage
IP Group
LondonSeed–Late Stage
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.





